CRISPR Therapeutics AG short interest in 2023
In 2023, CRISPR Therapeutics AG's disclosed short interest ran from 12.62% of shares outstanding on 13 Jan 2023 to 20.46% on 29 Dec 2023, a change of +7.84 percentage points. The year's high was 21.81% on 15 Dec 2023 and its low 12.62% on 13 Jan 2023, averaging 16.57% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.33 days on 15 Sep 2023. Full history: CRISPR Therapeutics AG.
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 12.62% (13 Jan 2023)
- End of year
- 20.46% (29 Dec 2023)
- Change
- +7.84 pp
- High
- 21.81% (15 Dec 2023)
- Low
- 12.62% (13 Jan 2023)
- Average
- 16.57%
- Highest days to cover
- 17.33 (15 Sep 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 12.62% | 8.54 | |
| 31 Jan 2023 | 12.75% | 10.46 | |
| 15 Feb 2023 | 13.09% | 9.37 | |
| 28 Feb 2023 | 14.26% | 8.05 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 15.55% | 12.85 | |
| 31 Mar 2023 | 16.22% | 13.44 | |
| 14 Apr 2023 | 16.53% | 8.67 | |
| 28 Apr 2023 | 16.86% | 10.78 | |
| 15 May 2023 | 15.75% | 6.74 | 10-Q filed, results (8-K) |
| 31 May 2023 | 15.45% | 9.84 | |
| 15 Jun 2023 | 15.80% | 8.65 | |
| 30 Jun 2023 | 15.93% | 11.55 | |
| 14 Jul 2023 | 15.59% | 13.82 | |
| 31 Jul 2023 | 15.34% | 13.06 | |
| 15 Aug 2023 | 16.88% | 10.93 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 17.74% | 15.89 | |
| 15 Sep 2023 | 17.36% | 17.33 | |
| 29 Sep 2023 | 16.42% | 15.45 | |
| 13 Oct 2023 | 17.07% | 11.76 | |
| 31 Oct 2023 | 17.49% | 9.09 | |
| 15 Nov 2023 | 20.61% | 5.69 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 20.05% | 4.58 | |
| 15 Dec 2023 | 21.81% | 3.61 | |
| 29 Dec 2023 | 20.46% | 6.80 |
See also: CRISPR Therapeutics AG's full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.